Once-Weekly Dulaglutide with Insulin Therapy for Type 2 Diabetes: Efficacy and Safety Results from a Phase 4, Randomized, Placebo-Controlled Study

INTRODUCTION: Although global studies have investigated the combination of dulaglutide with insulin in patients with type 2 diabetes mellitus (T2DM), differences in lean body mass and dulaglutide dosing can complicate the extrapolation of global study results to Japanese patients. This phase 4, rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishii, Hitoshi, Onishi, Yukiko, Oura, Tomonori, Takeuchi, Masakazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965529/
https://www.ncbi.nlm.nih.gov/pubmed/31758520
http://dx.doi.org/10.1007/s13300-019-00726-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965529/
https://www.ncbi.nlm.nih.gov/pubmed/31758520
http://dx.doi.org/10.1007/s13300-019-00726-8

Ejemplares similares